Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

February 10, LUMC Covid-19 Research Update

210210_LUMC_Update

Category: News and Announcements 2021By Richard Mollard February 10, 2021

Related posts

May 31, Top 20 Shareholders
June 1, 2021

May 14, Dr Kim Agnew Appointed PI of MPL Dog Cancer Trial
May 14, 2021

April 30, Top 20 Shareholders
May 1, 2021

April 29, Appendix 4C and Quarterly Update
April 29, 2021

April 27, Monepantel Phase IIb Dog Lymphoma Interim Plasma Data
April 27, 2021

April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021

Recent Articles

May 31, Top 20 Shareholders
June 1, 2021
May 14, Dr Kim Agnew Appointed PI of MPL Dog Cancer Trial
May 14, 2021
April 30, Top 20 Shareholders
May 1, 2021
April 29, Appendix 4C and Quarterly Update
April 29, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Elio D'Amato @Elio_DAmato·

Today's litter may not yet rule the roost, but these businesses have operations that support the booming pet industry and have big ambitions. Read more in my latest contribution to the @FinancialReview

https://bit.ly/3goNFUE

$AHX $MPA $EBO $PAA $IVC

Reply on Twitter 1404565332702883849 Retweet on Twitter 14045653327028838494 Like on Twitter 140456533270288384911 Twitter 1404565332702883849

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions